New Hope for Diabetes Management: FDA Approves Generic Dapagliflozin Amid Global Health Crisis
April 9, 2026 AHMEDABAD, India — In a move set to reshape the landscape of metabolic care, the U.S. Food and Drug Administration (FDA) has granted...
From One-Size-Fits-All to Precision Care: AIIMS Bhopal and Dutch Experts Launch ₹10 Crore Pharmacogenomics Initiative
BHOPAL, INDIA – In a transformative step toward personalizing healthcare for India’s diverse population, the All India Institute of Medical Sciences...
A Dual-Strike Strategy: New Drug Lunsekimig Could Redefine Asthma Control
PARIS – In a significant development for the millions of people living with persistent respiratory distress, pharmaceutical leader Sanofi has...
The Unseen Crisis in Sight: Over 45% of Eye Infection Bacteria in India Now Drug-Resistant
HYDERABAD — A groundbreaking genomic study released on April 6, 2026, has sent shockwaves through the ophthalmology community, revealing that nearly...
India Sets New Coronary Stent Price Caps for 2026: Balancing Patient Affordability with Medical Innovation
NEW DELHI — In a move to stabilize the cost of life-saving cardiac care, the National Pharmaceutical Pricing Authority (NPPA) has announced revised...
